Skip to main content
TipRanks
Go Ultimate75% OFF

Richard Peters Insider Profile

11 Followers

Richard Peters, Director at Aprea Therapeutics, holds 6.25K shares in Aprea Therapeutics (Ticker: APRE), holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK), holds 0.00 shares in Kineta (Ticker: KANT).

Richard Peters's Trading History

APRE
Aprea Therapeutics
Jun 17, 2026DirectorUninformative Buy―$2.60K
KANT
Kineta
Jul 02, 2025―Uninformative Sell―$0.00
MACK
Merrimack Pharmaceuticals
――――

You May Also Like

Richard Peters insider profile FAQ

What is the percentage of profitable transactions made by Richard Peters?
The percentage of profitable transactions made by Richard Peters is 67%.
What is the average return per transaction made by Richard Peters?
The average return per transaction made by Richard Peters is 5.00%.
What stocks does Richard Peters hold?
Richard Peters holds: APRE, MACK, KANT stocks.
What was Richard Peters's most profitable transaction?
Richard Peters’s most profitable transaction was an Informative Sell of KANT stock on July 6, 2022. The return on the trade was 24.60%.
What is Richard Peters's role in Aprea Therapeutics?
Richard Peters's role in Aprea Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.